Join to View Full Profile
177 Fort Washington AveMHB 6GN 435New York, NY 10032
Phone+1 212-305-3997
Fax+1 646-317-6321
Dr. Sacher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dana-Farber Cancer InstituteFellowship, 2014 - 2016
Harvard Medical SchoolMMSc, Genomics and Translational Research, 2014 - 2016
University of Toronto Faculty of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2014 - 2023
NY State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC Start of enrollment: 2017 Mar 01
Publications & Presentations
PubMed
- Corrigendum to 'Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research' [JTO Clinical and Research Reports Volume 6 Iss...Cheol-Kyu Park, Maryam Khalil, Nhu-An Pham, Stephanie Wong, Dalam Ly
JTO Clinical and Research Reports. 2025-05-01 - Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.Abdulrahman Alghabban, Lucy Corke, Hans Katzberg, Vera Bril, Carolina Barnett-Tapia
JTO Clinical and Research Reports. 2025-05-01 - Early phase trials: the perils of nonpublication.Adrian Sacher, Susan E Bates
The Oncologist. 2025-04-04
Journal Articles
- KRASG12C Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine
Press Mentions
In Case You Missed It: Roundup from ESMO Congress 2024November 19th, 2024- Young Investigators Awarded $200k to Study Innovative New Ways to Engage the Body’s Immune System to Fight Lung CancerJanuary 15th, 2021
Leukemia Drugs Hold Promise for Treatment-Resistant Lung CancerMarch 20th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
